Verified peer comparison
Immix Biopharma vs ASP Isotopes Financial Comparison
Direct answer
Immix Biopharma and ASP Isotopes are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free Immix Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Immix Biopharma Revenue
- 0 USD
- ASP Isotopes Revenue
- 23,849,000 USD
- Immix Biopharma Operating income
- -29,956,415 USD
- ASP Isotopes Operating income
- -57,191,000 USD